相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Leila Dorling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants
Rinat Bernstein-Molho et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms
Rinat Bernstein-Molho et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D. Beitsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women
Shreeya Patel et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel
Rinat Bernstein-Molho et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral
Sari Lieberman et al.
GENETICS IN MEDICINE (2017)
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry
Ranjit Manchanda et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Population genetic testing for cancer susceptibility: founder mutations to genomes
William D. Foulkes et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Counselling framework for moderate-penetrance cancer-susceptibility mutations
Nadine Tung et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil
Hagit Schayek et al.
CANCER GENETICS (2016)
Genetic features of Lynch syndrome in the Israeli population
Y. Goldberg et al.
CLINICAL GENETICS (2015)
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment
Heather Hampel et al.
GENETICS IN MEDICINE (2015)
Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
APC Polymorphisms and the Risk of Colorectal Neoplasia: A HuGE Review and Meta-Analysis
Jing Liang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Fasting glucose levels within the high normal range predict cardiovascular outcome
Kivity Shaye et al.
AMERICAN HEART JOURNAL (2012)
Common MUTYH mutations and colorectal cancer risk in multiethnic populations
Flavio Lejbkowicz et al.
FAMILIAL CANCER (2012)
Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome
L. Raskin et al.
CLINICAL GENETICS (2011)
High Risk of Colorectal and Endometrial Cancer in Ashkenazi Families With the MSH2 A636P Founder Mutation
Bhramar Mukherjee et al.
GASTROENTEROLOGY (2011)
Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
Nancie Petrucelli et al.
GENETICS IN MEDICINE (2010)
Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
Kelly A. Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
CHEK2* 1100delC genotyping for clinical assessment of breast cancer risk:: Meta-analyses of 26,000 patient cases and 27,000 controls
Maren Weischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Genetic epidemiology of BRCA mutations - family history detects less than 50% of the mutation carriers
Pal Moller et al.
EUROPEAN JOURNAL OF CANCER (2007)